7.260USD-1.43%Mkt Cap: 89.91M USDP/E: —Last update: 2026-06-01
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap89.91M USD
Enterprise Value83.56M USD
Revenue (TTM)4.28M USD
Gross Profit3.01M USD
Net Income (TTM)-7.80M USD
Revenue/Share0.4300 USD
Last Price7.260 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees24
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-123.50
PEG—
EV/EBITDA-12.71
EV/Revenue19.52
P/S21.43
P/B23.23
EPS (TTM)-0.80
EPS (Forward)-0.06
52W Range
2.19671% of range9.330
52W High9.330 USD
52W Low2.196 USD
Profitability
Gross Margin84.23%
Oper. Margin-108.26%
EBITDA Margin-153.58%
Profit Margin-218.55%
ROE-229.47%
ROA-121.81%
Growth
Revenue Growth79.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.43M USD
CapEx (TTM)131.15K USD
FCF Margin-81.66%
FCF Yield-3.89%
Net Debt-6.73M USD
Net Debt/EBITDA1.02
Balance Sheet
Debt/Equity0.12
Current Ratio2.89
Quick Ratio2.65
Book Value/Sh0.3190 USD
Cash/Share0.5720 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)11.00 USD
Target Range9.000 USD – 13.00 USD
# Analysts2
Ownership
Shares Out.12.38M
Float8.48M
Insiders21.43%
Institutions22.75%
Short Interest
Short Ratio2.0d
Short % Float4.17%
Short % Out.3.25%
Shares Short402.89K
Short (prev mo.)263.60K
Technical
SMA 507.506 (-3.3%)
SMA 2004.588 (+58.2%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)182.86K
Avg Vol (10d)118.69K
Technical Indicators
RSI (14)47.0
MACD-0.0869
MACD Signal0.0203
MACD Hist.-0.1072
BB Upper9.008 USD
BB Middle7.857 USD
BB Lower6.706 USD
BB Width29.30%
ATR (14)0.5816 USD
Vol Ratio (20d)0.41x